MedinCell S.A.
MEDCL | PA
Overview
Corporate Details
- ISIN(s):
- FR0004065605
- LEI:
- 969500R79U6PXCL2FF46
- Country:
- France
- Address:
- 3 RUE DES FRERES LUMIERE, 34830 JACOU
- Website:
- https://www.medincell.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
MedinCell® is a pharmaceutical company at premarketing stage that develops innovative long-acting injectable medicines in many therapeutic areas. Products of our portfolio are based on our BEPO® technology and aim to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier one pharmaceuticals companies and foundations to improve Global Health through new therapeutic options.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-17 17:45 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 405.2 KB | |
| 2025-06-17 17:45 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 395.7 KB | |
| 2025-06-10 18:00 |
Inside Information Statement
Inside Information / Other news releases
|
English | 185.6 KB | |
| 2025-06-10 18:00 |
Inside Information Statement
Informations privilégiées / Autres communiqués
|
French | 192.0 KB | |
| 2025-06-06 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 183.7 KB | |
| 2025-05-28 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 183.1 KB | |
| 2025-05-28 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 156.6 KB | |
| 2025-05-28 17:45 |
Regulatory News Service
Inside Information / Other news releases
|
English | 220.0 KB | |
| 2025-05-28 17:45 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 218.7 KB | |
| 2025-05-21 18:36 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 183.5 KB | |
| 2025-05-07 15:12 |
Earnings Release
Inside Information / Other news releases
|
English | 227.6 KB | |
| 2025-05-07 15:12 |
Earnings Release
Informations privilégiées / Autres communiqués
|
French | 217.5 KB | |
| 2025-04-22 18:11 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 194.3 KB | |
| 2025-04-22 18:11 |
Regulatory News Service
Inside Information / Other news releases
|
English | 208.5 KB | |
| 2025-04-15 19:48 |
Transaction in Own Shares
Informations privilégiées / Autres communiqués
|
French | 283.2 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-02 | N/A | Other | Sell | 60,000 | 600,006.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
OSE Immunotherapeutics | France | OSE | |
|
Ovoca Bio Plc | Ireland | OVXA | |
|
Oxford Biomedica PLC | United Kingdom | OXB | |
|
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | United Kingdom | OCTHF | |
|
Oxurion NV | Belgium | OXUR | |
|
PCI Biotech Holding | Norway | PCIB | |
|
Pentixapharm Holding AG | Germany | PTP | |
|
Perpetua Medical AB | Sweden | PERP | |
|
PharmaLundensis AB | Sweden | PHAL | |
|
Pharma Mar S.A. | Spain | PHM |